Table 2. Effect of RGZ on hematological parameters in control mice.
| LFD | LFD + RGZ | HFD | HFD + RGZ | |
| WBC (103/µl) | 7.67+/−0.48 | 5.99+/−0.57 | 9.18+-0.58 a | 7.06+/−1.14 |
| # NE (103/µl) | 2.02+/−0.22 | 1.45+/−0.18 | 2.19+/−0.21 | 1.58+/−0.22 |
| # LY (103/µl) | 5.92+/−0.52 | 4.19+−0.40 | 6.53+/−0.51 | 5.18+/−0.95 |
| # MO (103/µl) | 0.22+/−0.04 | 0.19+/−0.04 | 0.27+/−0.03 | 0.17+/−0.02 |
| # EO (103/µl) | 0.11+/−0.04 | 0.12+/−0.06 | 0.14+/−0.05 | 0.10+/−0.04 |
| # BA (103/µl) | 0.03+/−0.01 | 0.05+/−0.03 | 0.06+−0.02 | 0.03+−0.01 |
| %NE | 24.33+/−1.47 | 24.05+/−1.27 | 24.01+/−1.97 | 22.83+/−0.93 |
| %LY | 71.54+/−1.68 | 70.23+/−2.70 | 70.83+−2.89 | 72.14+/−1.89 |
| %MO | 2.55+/−0.26 | 2.99+/−0.47 | 3.02+/−0.35 | 2.64+−0.40 |
| %EO | 1.21+/−0.34 | 1.95+−0.74 | 1.54+−0.52 | 1.77+/−0.65 |
| %BA | 0.37+/−0.13 | 0.78+/−0.35 | 0.61+/−0.20 | 0.61+/−0.21 |
| RBC (106/µl) | 9.66+/−0.16 | 8.79+/−0.19 b | 10.00+/−0.06 | 8.84+/−0.26b |
| Hgb (g/dl) | 14.04+/−0.24 | 12.46+/−0.26 b | 14.35+/−0.15 | 12.30+/−0.34b |
| Hct | 45.28+/−1.31 | 39.8+/−1.04 b | 46.08+/−0.71 | 39.40+/−1.28b |
| MCV (fl) | 46.86+/−0.92 | 45.29+/−0.67 | 46.10+/−0.52 | 44.57+/−0.62 |
| MCH (pg/cell) | 14.55+/−0.20 | 14.16+/−0.13 | 14.35+/−0.10 | 13.93+/−0.17 |
| Platelets (103/µl) | 707+/−65 | 604+/−33 | 599+/−72 | 539+/−36 |
| MPV (fl) | 4.73+/−0.10 | 4.98+/−0.08 | 4.70+/−0.15 | 5.09+/−1.05 |
White blood cell (WBC) counts, Neutrophil (NE), Lymphocyte (LY), Monocyte (MO), Eosinophil (EO) and Basophil (BA) absolute numbers and percentages, Red Blood cell (RBC) numbers, Hemoglobin (Hgb) levels, Hematocrit (Hct), Mean corpuscolar volume (MCV), Mean corpuscolar hemoglobin (MCH), platelet number and Mean Platelet Volume (MPV) were evaluated on EDTA-anticoagulated peripheral blood using a Hemavet 950FS. Data are mean +/− SEM of 6–8 mice per group.
a
p<0.05 vs. each other group;
b
p<0.001 vs. respective group without RGZ by ANOVA.